EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-inflammatory effects of moxifloxacin and levofloxacin on cadmium-activated human astrocytes: Inhibition of proinflammatory cytokine release, TLR4/STAT3, and ERK/NF-κB signaling pathway

Suttinee Phuagkhaopong, Jidapha Sukwattanasombat, Kran Suknuntha, Christopher Power, Piyanuch Wonganan, Pornpun Vivithanaporn iD

PLOS ONE · 14.01.2025 · 20 (1) · e0317281

DOI: 10.1371/journal.pone.0317281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 14.01.2025. Verfasst von Suttinee Phuagkhaopong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand. Hauptthemen laut MEDLINE: Levofloxacin, Astrocytes, Moxifloxacin, Cadmium. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Chulalongkorn University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cadmium is a non-essential element and neurotoxin that causes neuroinflammation, which leads to neurodegenerative diseases and brain cancer. To date, there are no specific or effective therapeutic agents to control inflammation and alleviate cadmium-induced progressive destruction of brain cells. Fluoroquinolones (FQs), widely used antimicrobials with effective blood-brain barrier penetration, show promise in being repurposed as anti-inflammatory drugs. Therefore, we aimed to test the efficacy of repurposed FQs for the treatment of cadmium-induced inflammation using cultures of U-87 MG human astrocytes and primary human astrocytes. Both FQs abrogated cadmium-induced interleukin (IL)-6 and IL-8 release from human astrocytes in a concentration and time-dependent manner, although levofloxacin had a stronger inhibitory effect than moxifloxacin. The downregulation of inflammatory cytokine release occurred with a concomitant reduction in cadmium-induced elevations in p65 nuclear factor-κB (NF-κB) and extracellular signal-regulated kinases (ERKs) 1/2 phosphorylation. Additionally, levofloxacin treatment significantly alleviated cadmium-induced activation of phosphorylated NF-κB translocation and toll-like receptor (TLR)-4/signal transducer and activator of transcription (STAT) 3 signaling. Transcriptome analysis revealed that modulation of inflammation-related pathways was the most enriched after FQ treatment. Our data suggest that FQs, particularly levofloxacin, attenuate the inflammatory process mediated by cadmium in human astrocytes. These effects may be mediated, at least in part, by inhibition of immune pathways regulated by TLR4, STAT3, ERK MAPK, and NF-κB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevofloxacinAstrocytesMoxifloxacinCadmiumAnti-Inflammatory AgentsHumansSTAT3 Transcription FactorToll-Like Receptor 4NF-kappa BSignal TransductionCytokinesMAP Kinase Signaling SystemExtracellular Signal-Regulated MAP Kinases

Substanzen

LevofloxacinSTAT3 Transcription FactorMoxifloxacinToll-Like Receptor 4CadmiumNF-kappa BSTAT3 protein, humanAnti-Inflammatory AgentsCytokinesTLR4 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Interdisciplinary Program in Pharmacology, Graduate School, Chulalongkorn University, Bangkok, Thailand.
  • Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.
  • Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

ORCID-Profile: Pornpun Vivithanaporn

Förderung

  • Faculty of Medicine, Chulalongkorn University

Zitieren

APA

Phuagkhaopong, S., Sukwattanasombat, J., Suknuntha, K., Power, C., Wonganan, P., & Vivithanaporn, P. (2025). Anti-inflammatory effects of moxifloxacin and levofloxacin on cadmium-activated human astrocytes: Inhibition of proinflammatory cytokine release, TLR4/STAT3, and ERK/NF-κB signaling pathway. PLOS ONE, 20(1), e0317281. https://doi.org/10.1371/journal.pone.0317281

Vancouver

Phuagkhaopong S, Sukwattanasombat J, Suknuntha K, Power C, Wonganan P, Vivithanaporn P. Anti-inflammatory effects of moxifloxacin and levofloxacin on cadmium-activated human astrocytes: Inhibition of proinflammatory cytokine release, TLR4/STAT3, and ERK/NF-κB signaling pathway. PLOS ONE. 2025;20(1):e0317281. doi:10.1371/journal.pone.0317281

BibTeX
@article{Phuagkhaopong2025,
  author = {Phuagkhaopong, Suttinee and Sukwattanasombat, Jidapha and Suknuntha, Kran and Power, Christopher and Wonganan, Piyanuch and Vivithanaporn, Pornpun},
  title = {Anti-inflammatory effects of moxifloxacin and levofloxacin on cadmium-activated human astrocytes: Inhibition of proinflammatory cytokine release, TLR4/STAT3, and ERK/NF-κB signaling pathway},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {1},
  pages = {e0317281},
  doi = {10.1371/journal.pone.0317281}
}
Kostenlos starten →